The Gold Trade, May 24
Health Care: Drugs
Keryx Biopharmaceuticals Inc. (KERX: NASDAQ)
$8.03 0.00 | 0.00%
05/24/13 - 04:00 PM ET
1.04M / 2.88M
Vol / Avg. Vol:7.99 / 8.03
Open / Prev. Close:7.96 - 8.09
Today's Range:1.55 - 9.98
52 Wk Range:206.49%
Performance YTD:TheStreet Rating:
Portfolios with KERX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserBio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- User1st Time out
Latest KERX Headlines from TheStreet
- Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE) 05.21.13 | 10:05 am
- Rockwell Medical Run-Up Trade Follows Financing 05.21.13 | 08:05 am
- Short Interest Increases 10% For KERX 05.10.13 | 04:05 pm
- Keryx Biopharmaceuticals Inc. (KERX): Today's Featured Health Care Winner 04.22.13 | 05:04 pm
- Today's Drugs Industry Featured Laggard: Keryx Biopharmaceuticals Inc. (KERX) 04.11.13 | 05:04 pm
- Bears Eat Herbalife, JC Penney - Bulls Find Keryx
04.09.13 | 12:04 pm - Keryx Biopharmaceuticals Inc. (KERX): Health Care's Highlighted Dud Of The Day 03.26.13 | 05:03 pm
- Keryx CEO vs. A Short Seller: Zerenex Patent Debate 03.13.13 | 07:03 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 03.08.13 | 07:03 pm
- Why Expect More Price Swings From These 4 Biotechs 02.28.13 | 11:02 am
Press Releases for KERX
- Keryx Biopharmaceuticals, Inc. To Host Conference Call On First Quarter 2013 Financial Results - PR Newswire 05.06.13 | 04:05 pm
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Keryx Biopharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2013 To Seek A Lead Plaintiff Position - Business Wire 03.25.13 | 08:03 am
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Keryx Biopharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2013 To Seek A Lead Plaintiff Position - PR Newswire 03.19.13 | 06:03 pm
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Keryx Biopharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2013 To Seek A Lead Plaintiff Position - Business Wire 03.18.13 | 05:03 pm
- Keryx Biopharmaceuticals To Present At The 25th Annual ROTH Conference - PR Newswire 03.14.13 | 08:03 am
- Keryx Biopharmaceuticals Announces Appointment Of Amit Sharma, M.D. As Vice President, Medical Affairs - PR Newswire 03.13.13 | 08:03 am
- Keryx Biopharmaceuticals, Inc. To Host Conference Call On Fourth Quarter And Year-End 2012 Financial Results - PR Newswire 03.11.13 | 08:03 am
- Keryx Biopharmaceuticals To Present At The Citigroup 2013 Global Healthcare Conference - PR Newswire 02.22.13 | 08:02 am
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact The Firm - PR Newswire 02.08.13 | 09:02 pm
- Harwood Feffer LLP Announces Investigation Of Keryx Biopharmaceuticals, Inc. - PR Newswire 02.08.13 | 12:02 pm
Partner Headlines for KERX
- Zerenex Phase III Data Imminent; Odds Still High For Keryx To Succeed With This Drug - Seeking Alpha 01.22.13 | 09:01 am
- Dawson James Securities Reiterates Market Outperform Rating, $4 PT on Keryx Biopharmaceuticals - Benzinga 11.28.12 | 09:11 am
- Healthcare Biz Roundup: Keryx Jumps Without CAUSE, Teva Not A MONOPOLIST - Wall St. Cheat Sheet 07.04.12 | 08:07 am
- Zacks' Voice of the People highlights opportunities with Starbucks, Realty Income, Keryx Biopharma, Bon-Ton Stores and Orexigen Therapeutics - Press Releases - Zacks 04.12.12 | 09:04 am
- 2 Biotech Stocks To Consider Now, 1 To Avoid - Seeking Alpha 04.10.12 | 09:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.16.12 | 05:03 pm
- Morning Social Media Outlook for Tuesday Mar 6 (SHFL, HAR, PCX, NTRI) - Benzinga 03.06.12 | 09:03 am
- FDA Approval Practically A Done Deal For Keryx And AEterna Zentaris - Seeking Alpha 03.02.12 | 05:03 pm
- 3 Boring Dividend Stocks You Will Grow To Love - Seeking Alpha 02.26.12 | 07:02 am
